Citation Impact
Citing Papers
Psychiatric and Medical Effects of Anabolic-Androgenic Steroid Use
1994 Standout
On the importance and mechanisms of burst release in matrix-controlled drug delivery systems
2001 Standout
Contraceptive failure in the United States
2011 Standout
Experiences of injectable contraceptive users in an urban setting
1996
Serum sex hormone-binding globulin, cardiovascular risk factors, and adrenal cortisol responses to dexamethasone and corticotropin
1993
Androgen Abuse by Athletes
1988
An Exploration of the Drive for Muscularity in Adolescent Boys and Girls
2000 Standout
Use of doping agents, particularly anabolic steroids, in sports and society
2008 Standout
Adolescents and Norplant: Preliminary findings of side effects
1995
Norplant® implants and progesterone vaginal rings do not affect maternal bone turnover and density during lactation and after weaning
1999
The US etonogestrel implant mandatory clinical training and active monitoring programs: 6-year experience
2016
In VivoEffects of Sex Steroids on Lymphocyte Responsiveness and Immunoglobulin Levels in Humans
2000
Epidemiology of Prostate Cancer
2019 Standout
Phyto-oestrogens and Western Diseases
1997 Standout
Wound Healing Dressings and Drug Delivery Systems: A Review
2007 Standout
Biochemical and Physiological Aspects of Endogenous Androgens
2009
The cardiac toxicity of anabolic steroids
1998
The effectiveness of the levonorgestrel‐releasing intrauterine system in menorrhagia: a systematic review
2001
Myocardial infarction and third generation oral contraceptives: aggregation of recent studies
2002
Oral progestogen-only contraceptives and cardiovascular risk: Results from the Transnational Study on Oral Contraceptives and the Health of Young Women
1999
Polycystic Ovary Syndrome
1995 Standout
Androgenic Anabolic Steroid Abuse and the Cardiovascular System
2009
Does obesity diminish the positive effect of oral contraceptive treatment on hyperandrogenism in women with polycystic ovarian syndrome?
2001
Effects of chronically high doses of the anabolic androgenic steroid, testosterone, on intermale aggression and sexual behavior in male rats
1994
Clinical evaluation, dose-finding and acceptability of AERODIOL®, the pulsed estrogen therapy for treatment of climacteric symptoms
2001
Contraceptive Technology
2021 Standout
Randomized trial to evaluate contraceptive efficacy, safety and acceptability of a two-rod contraceptive implant over 4 years in the Dominican Republic
2019
Cyclodextrin-based pharmaceutics: past, present and future
2004 Standout
Epidemiological and Policy Issues in the Measurement of the Long Term Health Effects of Anabolic-Androgenic Steroids
1989
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
2011 Standout
Effects of levonorgestrel-releasing subdermal contraceptive implants on bone density and bone metabolism
1999
Anabolic Steroids
2002
Biobehavioral responses to stress in females: Tend-and-befriend, not fight-or-flight.
2000 Standout
Toxicology of progestogens of implantable contraceptives for women
2002
Ovarian function during use of vaginal rings delivering three different doses of Nestorone®
2001
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Pharmaceutical and therapeutic Potentials of essential oils and their individual volatile constituents: a review
2007 Standout
Endogenous thrombin potential is higher during the luteal phase than during the follicular phase of a normal menstrual cycle
2013 StandoutNobel
Neuroendocrine and behavioral effects of high-dose anabolic steroid administration in male normal volunteers
2003
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Hormonal contraceptives for contraception in overweight or obese women
2013
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)
2007 Standout
The Complex Role of Estrogens in Inflammation
2007 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Mechanisms of solute release from porous hydrophilic polymers
1983 Standout
Side Effects of Anabolic Steroids in Weight-Trained Men
1983
Lipid metabolism in women with polycystic ovary syndrome: possible implications for an increased risk of coronary heart disease
1984
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration
2014 Standout
Atherogenic Effects of Anabolic Steroids on Serum Lipid Levels
1991
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Implantable contraceptives (subdermal implants and hormonally impregnated intrauterine systems) versus other forms of reversible contraceptives: two systematic reviews to assess relative effectiveness, acceptability, tolerability and cost-effectiveness.
2000
Sex Steroids, Insulin, and Arterial Stiffness in Women and Men
1999
Post-menopausal hormone replacement therapy: effects of progestogens on serum lipids and lipoproteins. A review
1986
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Desire for Weight Gain and Potential Risks of Adolescent Males Using Anabolic Steroids
1994
Transdermal Estradiol
1992
Plasma estradiol, free testosterone, sex hormone binding globulin binding capacity, and prolactin in benign prostatic hyperplasia and prostatic cancer
1983
Phytoestrogens: epidemiology and a possible role in cancer protection.
1995 Standout
ProTox-II: a webserver for the prediction of toxicity of chemicals
2018 Standout
Contraception with levonorgestrel-releasing subdermal capsules, NorplantTM, after pregnancy termination
1983
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women
1995 Standout
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
2016 Standout
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
2013 Standout
Estimated Prevalence of Anabolic Steroid Use Among Male High School Seniors
1988
Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor VLeiden mutation: a randomized trial
2003
Diet and plasma androgens in postmenopausal vegetarian and omnivorous women and postmenopausal women with breast cancer
1989
Hormonal contraceptives for contraception in overweight or obese women
2016
Anabolic steroids: A review of the literature
1984
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline
2017 Standout
Atherogenic effects of anabolic steroids on serum lipid levels. A literature review.
1991
Diet and serum sex hormones in healthy men
1984
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Anabolic-Androgenic Steroid Use in the United States
1993 Standout
INVITED REVIEW POLYMERIC DELIVERY SYSTEMS FOR CONTROLLED DRUG RELEASE
1980
Decrease of serum total and free testosterone during a low-fat high-fibre diet
1983
Anabolic-Androgenic Steroid Therapy in the Treatment of Chronic Diseases
2001
Enhanced metabolism of levonorgestrel during phenytoin treatment in a woman with Norplant® implants
1986
Works of Pentti Holma being referenced
The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study
1998
Norplant® Consensus Statement and Background Review
1998
Clinical performance of a new two-rod levonorgestrel contraceptive implant: A three-year randomized study with Norplant® implants as controls
1997
Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices
1992
Contraception with long acting subdermal implants: II. Measured and perceived effects in international clinical trials
1978
Contraception with long acting subdermal implants: I. An effective and acceptable modality in international clinical trials
1978
Prolonged effectiveness of Norplant® capsule implants: a 7-year study
2000
Transdermal oestrogen replacement therapy in a Finnish population
1991
EFFECT OF AN ANABOLIC STEROID (METANDIENON) ON PLASMA LH, FSH, AND TESTOSTERONE AND ON THE RESPONSE TO INTRAVENOUS ADMINISTRATION OF LRH
1976
A Four-Year Clinical Study of NORPLANT Implants
1983
Three-year experience with NORPLANT™ subdermal contraception
1983
Effects of oral contraceptive combinations containing levonorgestrel or desogestrel on serum proteins and androgen binding
1981
Effects of an anabolic steroid (metandienone) on spermatogenesis
1977
Effect of an anabolic steroid (metandienone) on central and peripheral blood flow in well-trained male athletes.
1977
Serum lipids and proteins during treatment with a new oral contraceptive combination containing desogestrel
1983
[Anabolic steroids in sports].
1978